Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Braakman

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cancer Immunology, Immunotherapy : CII|January 1, 1991
T cell targeting in cancer therapyR L Bolhuis, E Sturm, E Braakman
Journal of Cellular Biochemistry|December 1, 1991
Engineering T lymphocyte antigen specificityR L Bolhuis, E Sturm, J W Gratama, et al.
Clinical and Experimental Immunology|November 1, 1986
Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuitE Braakman, A van Tunen, A Meager, et al.
Cellular Immunology|February 1, 1988
Recognition of influenza virus-infected B-cell lines by human influenza virus-specific CTLF T Rotteveel, E Braakman, B Robbe, et al.
Cellular Immunology|May 1, 1986
IL-2- and IFN gamma-enhanced natural cytotoxic activity: analysis of the role of different lymphoid subsets and implications for activation routesE Braakman, A van Tunen, A Meager, et al.
Cellular Immunology|July 1, 1986
The role of IL-2 and T4+ cells in the generation of human influenza virus-specific CTL activityE Braakman, P Treep-Van Leeuwen, E E Roosnek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1990
Human V gamma 9-V delta 2 T cell receptor-gamma delta lymphocytes show specificity to Daudi Burkitt's lymphoma cellsE Sturm, E Braakman, P Fisch, et al.
Immunodeficiency|January 1, 1993
Bone marrow gene therapy for adenosine deaminase deficiencyL C Kaptein, M P Einerhand, E Braakman, et al.
International Immunology|January 1, 1990
Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysisP S Goedegebuure, E Braakman, D M Segal, et al.
Immunology Today|October 26, 2014
Are MHC class II-restricted cytotoxic T lymphocytes important?E Braakman, F T Rotteveel, G van Bleek, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cancer Immunology, Immunotherapy : CII|January 1, 1991
T cell targeting in cancer therapyR L Bolhuis, E Sturm, E Braakman
Journal of Cellular Biochemistry|December 1, 1991
Engineering T lymphocyte antigen specificityR L Bolhuis, E Sturm, J W Gratama, et al.
Clinical and Experimental Immunology|November 1, 1986
Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuitE Braakman, A van Tunen, A Meager, et al.
Cellular Immunology|February 1, 1988
Recognition of influenza virus-infected B-cell lines by human influenza virus-specific CTLF T Rotteveel, E Braakman, B Robbe, et al.
Cellular Immunology|May 1, 1986
IL-2- and IFN gamma-enhanced natural cytotoxic activity: analysis of the role of different lymphoid subsets and implications for activation routesE Braakman, A van Tunen, A Meager, et al.
Cellular Immunology|July 1, 1986
The role of IL-2 and T4+ cells in the generation of human influenza virus-specific CTL activityE Braakman, P Treep-Van Leeuwen, E E Roosnek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1990
Human V gamma 9-V delta 2 T cell receptor-gamma delta lymphocytes show specificity to Daudi Burkitt's lymphoma cellsE Sturm, E Braakman, P Fisch, et al.
Immunodeficiency|January 1, 1993
Bone marrow gene therapy for adenosine deaminase deficiencyL C Kaptein, M P Einerhand, E Braakman, et al.
International Immunology|January 1, 1990
Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysisP S Goedegebuure, E Braakman, D M Segal, et al.
Immunology Today|October 26, 2014
Are MHC class II-restricted cytotoxic T lymphocytes important?E Braakman, F T Rotteveel, G van Bleek, et al.
Pageof 4